Biomedical researchers at the University of Virginia School of Medicine published a clinical study in the Journal of Clinical Investigation, unveiling an innovative therapeutic strategy against aggressive glioblastoma brain tumors using acoustic energy. The therapeutic protocol combines magnetic resonance imaging-guided low-intensity focused ultrasound with engineered lipid nanoparticles to temporarily disrupt the blood-brain barrier. This localized opening allows synthetic therapeutic microRNAs to penetrate deep into tumor tissues that were previously unreachable due to protective cranial vascular membranes.
Preclinical laboratory trials revealed that targeted delivery of regulatory microRNA molecules disrupted critical oncogenic signaling cascades, effectively halting tumor cell proliferation and sensitizing malignant tissues to standard radiotherapy treatments. Attending neuro-oncologists highlighted that focused ultrasound avoids invasive cranial surgery while restricting therapeutic agent concentrations exclusively to diseased brain regions, sparing adjacent healthy neural networks. The research team is currently preparing phase one human clinical protocols, offering renewed hope for patients facing one of the most lethal forms of central nervous system malignancy.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/releases/2026/10/261030003017.htm